ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

AGLE Company Profile and Key Details

NASDAQ : AGLE

Aeglea BioTherapeutics, Inc.

$12.01

0.75+6.66%

At Close 4:00 PM

Not Actively Trading

65.05

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

AGLE Stock Price Chart

Stock Price Today

Aeglea BioTherapeutics, Inc. (AGLE) stock surged +6.66%, trading at $12.01 on NASDAQ, up from the previous close of $11.26. The stock opened at $10.87, fluctuating between $10.69 and $12.34 in the recent session.

Stock Snapshot

11.26

Prev. Close

10.87

Open

48.63M

Market Cap

4.05M

Number of Shares

10.69

Day Low

12.3399

Day High

-0.1619689817936615

P/E Ratio

47.47%

Free Float in %

-74.15

EPS (TTM)

-57.15

Book Value

-20.26

Cash Flow per Share

43.24K

Volume

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Dec 26, 2023	18.11	19.60	17.83	19.30	91.64K
Dec 22, 2023	17.10	18.40	16.90	18.17	81.31K
Dec 21, 2023	15.68	17.45	15.60	17.22	142.82K
Dec 20, 2023	17.09	17.81	15.41	15.55	136.49K
Dec 19, 2023	15.82	16.61	15.37	16.40	114.01K
Dec 18, 2023	16.83	16.83	15.63	15.81	83.4K
Dec 15, 2023	14.95	15.65	14.62	15.50	122.33K
Dec 14, 2023	16.00	17.22	14.22	14.84	348.21K
Dec 13, 2023	16.39	18.10	16.03	16.52	71.4K
Dec 12, 2023	17.85	18.88	15.94	16.50	275.67K
Dec 11, 2023	21.29	21.29	18.03	18.05	285.12K
Dec 08, 2023	20.39	21.83	19.61	19.61	369.17K
Dec 07, 2023	20.14	21.19	17.04	19.86	466.59K
Dec 06, 2023	19.43	22.66	19.43	20.25	33.83K
Dec 05, 2023	19.10	21.61	17.20	20.50	20.44K
Dec 04, 2023	19.50	19.50	17.20	19.29	26.42K
Dec 01, 2023	18.77	21.40	16.24	19.38	86.45K
Nov 30, 2023	15.31	19.60	14.38	18.66	121.64K
Nov 29, 2023	15.51	16.88	15.44	15.72	101.84K
Nov 28, 2023	10.81	16.30	10.42	14.50	116.51K

Contact Details

Austin, TX 78746

United States

Website: https://www.aeglea.comContact: 512 942 2935

About Company

Aeglea BioTherapeutics, Inc., a clinical-stage biotechnology company, designs and develops human enzyme therapeutics for the treatment of patients and families with rare metabolic diseases. The company's lead product candidate is pegzilarginase, a recombinant human Arginase 1 that is in Phase III PEACE trial to evaluate the safety and efficacy for the treatment of Arginase 1 deficiency. It also develops AGLE-177, a polyethylene glycol modified, which is in Phase I/II clinical trial for the treatment of patient with homocystinuria. In addition, the company's preclinical pipeline includes AGLE-325 for the treatment of cystinuria, as well as other research programs. The company was formerly known as Aeglea BioTherapeutics Holdings, LLC and changed its name to Aeglea BioTherapeutics, Inc. in March 2015. Aeglea BioTherapeutics, Inc. was founded in 2013 and is headquartered in Austin, Texas.

Frequently Asked Questions

What is the current Aeglea BioTherapeutics, Inc. (AGLE) stock price?

Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE) stock price is $12.01 in the last trading session. During the trading session, AGLE stock reached the peak price of $12.34 while $10.69 was the lowest point it dropped to. The percentage change in AGLE stock occurred in the recent session was 6.66% while the dollar amount for the price change in AGLE stock was $0.75.

AGLE's industry and sector of operation?

The NASDAQ listed AGLE is part of Biotechnology industry that operates in the broader Healthcare sector. Aeglea BioTherapeutics, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of AGLE?

Dr. Linda Neuman M.D., MBA
Chief Medical Officer
Dr. Josie Gayton Ph.D.
Senior Vice President of Program Strategy, Operations & Chief of Staff
Dr. Kelly Boothe Ph.D.
Senior Director of Corporation Communications & Investor Relations
Joey Perrone
Vice President of Fin. & Investor Relations
Dr. Scott W. Rowlinson
Vice President of Research
Mr. James Paul Kastenmayer J.D., Ph.D.
Consultant
Mr. Jonathan D. Alspaugh M.B.A.
Pres, Chief Financial Officer & Principal Accounting Officer
Dr. Cameron Turtle DPHIL, Ph.D.
Chief Operating Officer
Mr. Jeffrey M. Goldberg
Pres, Chief Executive Officer & Director
Dr. Leslie S. Sloan Ph.D.
Chief Operating Officer
Ms. Cortney Caudill M.B.A.
Chief Product Officer
Dr. F. Andrew Dorr
Executive Officer
Ms. Tricia Sterling
Vice President of Patient Affairs
Mr. Michael C. Hanley M.B.A.
Chief Commercial Officer & Chief Bus. Officer

How AGLE did perform over past 52-week?

AGLE's closing price is 351.5% higher than its 52-week low of $2.66 where as its distance from 52-week high of $24.00 is -49.96%.

How many employees does AGLE have?

Number of AGLE employees currently stands at 69.

Link for AGLE official website?

Official Website of AGLE is: https://www.aeglea.com

How do I contact AGLE?

AGLE could be contacted at phone 512 942 2935 and can also be accessed through its website. AGLE operates from 805 Las Cimas Parkway, Austin, TX 78746, United States.

How many shares of AGLE are traded daily?

AGLE stock volume for the day was 43.24K shares. The average number of AGLE shares traded daily for last 3 months was 59.54K.

What is the market cap of AGLE currently?

The market value of AGLE currently stands at $48.63M with its latest stock price at $12.01 and 4.05M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

Home About Meet The Team Contact Us Privacy Policy Newsletter

AGLE Stock Price Chart

Stock Price Today

Stock Snapshot

11.26

Prev. Close

10.87

Open

48.63M

Market Cap

4.05M

Number of Shares

10.69

Day Low

12.3399

Day High

-0.1619689817936615

P/E Ratio

47.47%

Free Float in %

-74.15

EPS (TTM)

-57.15

Book Value

-20.26

Cash Flow per Share

43.24K

Volume

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Dec 26, 2023	18.11	19.60	17.83	19.30	91.64K
Dec 22, 2023	17.10	18.40	16.90	18.17	81.31K
Dec 21, 2023	15.68	17.45	15.60	17.22	142.82K
Dec 20, 2023	17.09	17.81	15.41	15.55	136.49K
Dec 19, 2023	15.82	16.61	15.37	16.40	114.01K
Dec 18, 2023	16.83	16.83	15.63	15.81	83.4K
Dec 15, 2023	14.95	15.65	14.62	15.50	122.33K
Dec 14, 2023	16.00	17.22	14.22	14.84	348.21K
Dec 13, 2023	16.39	18.10	16.03	16.52	71.4K
Dec 12, 2023	17.85	18.88	15.94	16.50	275.67K
Dec 11, 2023	21.29	21.29	18.03	18.05	285.12K
Dec 08, 2023	20.39	21.83	19.61	19.61	369.17K
Dec 07, 2023	20.14	21.19	17.04	19.86	466.59K
Dec 06, 2023	19.43	22.66	19.43	20.25	33.83K
Dec 05, 2023	19.10	21.61	17.20	20.50	20.44K
Dec 04, 2023	19.50	19.50	17.20	19.29	26.42K
Dec 01, 2023	18.77	21.40	16.24	19.38	86.45K
Nov 30, 2023	15.31	19.60	14.38	18.66	121.64K
Nov 29, 2023	15.51	16.88	15.44	15.72	101.84K
Nov 28, 2023	10.81	16.30	10.42	14.50	116.51K

Contact Details

Austin, TX 78746

United States

Website: https://www.aeglea.comContact: 512 942 2935

About Company

Frequently Asked Questions

What is the current Aeglea BioTherapeutics, Inc. (AGLE) stock price?

AGLE's industry and sector of operation?

Who are the executives of AGLE?

How AGLE did perform over past 52-week?

AGLE's closing price is 351.5% higher than its 52-week low of $2.66 where as its distance from 52-week high of $24.00 is -49.96%.

How many employees does AGLE have?

Number of AGLE employees currently stands at 69.

Link for AGLE official website?

Official Website of AGLE is: https://www.aeglea.com

How do I contact AGLE?

AGLE could be contacted at phone 512 942 2935 and can also be accessed through its website. AGLE operates from 805 Las Cimas Parkway, Austin, TX 78746, United States.

How many shares of AGLE are traded daily?

AGLE stock volume for the day was 43.24K shares. The average number of AGLE shares traded daily for last 3 months was 59.54K.

What is the market cap of AGLE currently?

The market value of AGLE currently stands at $48.63M with its latest stock price at $12.01 and 4.05M of its shares outstanding.

Employees	69
Beta	2.57
Sales or Revenue	$2.33M
5Y Sales Change%	-1%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	69
Beta	2.57
Sales or Revenue	$2.33M
5Y Sales Change%	-1%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

AGLE Company Profile and Key Details

Aeglea BioTherapeutics, Inc.

AGLE Stock Price Chart

Stock Price Today

Stock Snapshot

Stock Price History Chart

Contact Details

About Company

Company Information

Frequently Asked Questions

AGLE Stock Price Chart

Stock Price Today

Stock Snapshot

Stock Price History Chart

Contact Details

About Company

Company Information

Frequently Asked Questions